Crohn's Disease and Colitis Trial, Recruiting NCT06571669 Sponsor: Boomerang Medical Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06571669
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female
  • People aged between 18 and 85 years old
  • People who have been diagnosed with ulcerative colitis
  • People who are willing and able to sign a consent form agreeing to take part
  • People who are able and willing to follow the study plan and attend all required follow-up appointments

Who may not be able to join:

  • People who have a significant health condition that could interfere with the study procedures or equipment, or that could affect the results
  • People who have a psychiatric or personality disorder, as determined by the study investigator
  • People who have an active bacterial infection that carries a risk of the infection spreading through the bloodstream (for example, an abscess)
  • People who have an active Clostridioides difficile (C. diff) infection of the colon
  • People who have an active cytomegalovirus (CMV) infection of the colon
  • People who have evidence of a hole or tear in the colon
  • People who have very severe colitis that requires emergency surgery
  • People who have microscopic, ischemic, or infectious colitis (types of colon inflammation with specific causes — confirm with trial site)
  • People who have an unremoved growth or abnormal tissue in the colon
  • People who have a narrowing in the colon that a colonoscopy camera cannot pass through
  • People who currently have cancer anywhere in the digestive tract
  • People who are currently taking part in another clinical trial
  • People who have previously had surgery for ulcerative colitis, or who are likely to need such surgery
  • People who have previously had a nerve stimulation device implanted, or who have taken part in a nerve stimulation trial before
  • People who are unable to operate the patient control device provided as part of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 210-722-6192

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boomerang Medical
Registry
ClinicalTrials.gov
Start date
31 January 2025
Est. completion
28 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Bowel Urgency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov